lynozyfic

Frequently asked questions

What does Lynozyfic treat?

Lynozyfic (Linvoseltamab-Gcpt) may be used to treat multiple myeloma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Lynozyfic?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Lynozyfic. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Lynozyfic?

Lynozyfic is marketed by Rengeneron Pharmaceuticals, Inc.. You can see Rengeneron Pharmaceuticals, Inc.'s full profile, rating, and other products on pharmaranks.

Is Lynozyfic a brand-name or generic drug?

Lynozyfic is a brand-name product with the active ingredient Linvoseltamab-Gcpt.

Is Lynozyfic available over the counter?

No. Lynozyfic is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Lynozyfic come in?

Lynozyfic is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Lynozyfic FDA-registered?

Lynozyfic is on record with the U.S. FDA under application number BLA761400. You can verify this on its official FDA label.